BioMarin Reports First Quarter 2026 Financial and Operating Results
Go back to BioMarin Reports First Quarter 2026 Financial and Operating Results| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.95 +0.41 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.54 | 52 Week High | $108.96 | |||
| Open | $55.54 | 52 Week Low | $62.12 | |||
| Day High | $56.26 | P/E | N/A | |||
| Day Low | $55.48 | EPS | $-1.27 | |||
| Volume | 1,093,938 | |||||
